HealthEquity, Inc. (NASDAQ:HQY) Shares Purchased by State Street Corp

State Street Corp boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 0.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,131,900 shares of the company’s stock after acquiring an additional 23,613 shares during the period. State Street Corp owned 3.59% of HealthEquity worth $256,346,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Quarry LP lifted its stake in HealthEquity by 418.8% during the third quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after purchasing an additional 1,089 shares in the last quarter. Motley Fool Asset Management LLC increased its position in shares of HealthEquity by 0.5% during the third quarter. Motley Fool Asset Management LLC now owns 111,757 shares of the company’s stock worth $8,971,000 after acquiring an additional 531 shares during the period. Holocene Advisors LP purchased a new stake in shares of HealthEquity during the third quarter worth $1,246,000. Centiva Capital LP purchased a new stake in shares of HealthEquity during the third quarter worth $366,000. Finally, Wasatch Advisors LP increased its position in shares of HealthEquity by 6.6% during the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after acquiring an additional 483,269 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Stock Down 5.6 %

Shares of NASDAQ HQY opened at $95.39 on Wednesday. HealthEquity, Inc. has a 1 year low of $62.10 and a 1 year high of $105.82. The firm’s 50 day moving average price is $93.11 and its 200 day moving average price is $83.90. The firm has a market cap of $8.33 billion, a P/E ratio of 79.49, a price-to-earnings-growth ratio of 1.57 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Barrington Research upped their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. JMP Securities upped their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday. The Goldman Sachs Group started coverage on HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Deutsche Bank Aktiengesellschaft increased their target price on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Finally, Royal Bank of Canada increased their target price on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $110.71.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Frank Corvino sold 1,247 shares of HealthEquity stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the transaction, the director now owns 4,823 shares in the company, valued at $387,093.98. The trade was a 20.54 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 10,536 shares of company stock worth $884,517. 2.20% of the stock is owned by insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.